Journal of Clinical Endocrinology & Metabolism, Vol 79, 1582-1586, Copyright © 1994 by Endocrine Society

ARTICLES

Direct regulation of human myometrial contractions by human chorionic gonadotropin

E Eta, G Ambrus and CV Rao
Department of Obstetrics and Gynecology, University of Louisville School of Medicine, Kentucky 40292.

Our laboratory previously demonstrated that the human myometrium contains functional hCG/LH receptors. The present study investigated whether hCG can directly regulate oxytocin-stimulated human myometrial contractions. Uterine specimens were obtained from 30- to 40-yr-old women undergoing hysterectomy for leiomyomata, metrorrhagia, or prolapse. Myometrial strips from the lower uterine segment were primed for 24 h with 2.2 nmol/L estradiol. Then, the slices were incubated for 4 h at 37 C with or without 10 nmol/L hCG and stimulated with 1 mumol/L oxytocin, and the contractions were measured. The results showed that hCG inhibited the amplitude while paradoxically increasing the frequency of contractions. The effect of hCG was seen in proliferative, but not secretory, phase myometrial specimens. hCG had no effect on rat hepatic portal vein smooth muscle contractions, suggesting that the hCG action was tissue specific. Oxytocin treatment of human myometrial smooth muscle cells resulted in a dose-dependent increase in intracellular free Ca2+ levels. Pretreatment with hCG resulted in an attenuation of the oxytocin response, suggesting that the action of hCG was mediated by decreasing intracellular free Ca2+ levels. In summary, our results demonstrate that hCG can directly inhibit the amplitude of oxytocin-stimulated contractions of human myometria from the proliferative phase of the cycle. The hCG action is tissue specific and appears to be mediated by decreasing intracellular free Ca2+ levels in myometrial smooth muscle cells.

This article has been cited by other articles:

				R. J. Phillips, A. J. Tyson-Capper (nee Pollard), J. Bailey, S. C. Robson, and G. N. Europe-Finner Regulation of Expression of the Chorionic Gonadotropin/Luteinizing Hormone Receptor Gene in the Human Myometrium: Involvement of Specificity Protein-1 (Sp1), Sp3, Sp4, Sp-Like Proteins, and Histone Deacetylases J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3479 - 3490. [Abstract] [Full Text] [PDF]

				H. C. Doheny, D. D. Houlihan, N. Ravikumar, T. J. Smith, and J. J. Morrison Human Chorionic Gonadotrophin Relaxation of Human Pregnant Myometrium and Activation of the BKCa Channel J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4310 - 4315. [Abstract] [Full Text] [PDF]

				P. C. Lin, X. Li, Z. M. Lei, and Ch. V. Rao Human Cervix Contains Functional Luteinizing Hormone/Human Chorionic Gonadotropin Receptors J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3409 - 3414. [Abstract] [Full Text] [PDF]

				E. A. Stewart Gonadotropins and the Uterus: Is There a Gonad-Independent Pathway? Reproductive Sciences, December 1, 2001; 8(6): 319 - 326. [Abstract] [PDF]

				X.-L. Zhou, Z. M. Lei, and Ch. V. Rao Treatment of Human Endometrial Gland Epithelial Cells with Chorionic Gonadotropin/Luteinizing Hormone Increases the Expression of the Cyclooxygenase-2 Gene J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3364 - 3377. [Abstract] [Full Text]

				N. S. Panesar and C. W. Poon hCG: its pancreatic and duodenal receptors and in vivo electrolyte secretion in female rats Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1430 - G1436. [Abstract] [Full Text] [PDF]